Flu-Like Symptoms Concealed Aggressive Blood Cancer Diagnosis
When Alana Matthews found herself unable to shake off what seemed like a severe bout of flu at the end of 2023, she attributed it to seasonal viruses circulating widely. Despite two visits to her general practitioner, where she was informed it was likely the lingering effects of a chest infection, her health continued to deteriorate alarmingly.
A Devastating Discovery After Breathing Struggles
The situation reached a critical point when Alana, then aged 26, struggled to keep pace with her partner and friends during a simple walk, leaving them deeply concerned. Her partner, Charlie Matthews, was compelled to dial 999 after she experienced severe breathing difficulties, leading to her urgent hospital admission.
Medical tests delivered the devastating news: rather than flu or a chest infection, Alana was diagnosed with acute myeloid leukaemia (AML), an exceptionally aggressive form of blood cancer. AML ranks among the most challenging blood cancers to treat, with survival rates remaining distressingly low for many patients.
An 18-Month Fight Against the Disease
Tragically, despite undergoing intensive chemotherapy and achieving remission by July 2024—even graduating university with a first-class degree during a brief recovery period—Alana's cancer returned shortly thereafter. She participated in clinical trials testing novel drug combinations, which initially showed promise, but further aggressive treatments ultimately proved ineffective.
When doctors conveyed there were no remaining treatment options, Alana and Charlie organised their wedding in just five days, creating a beautiful, emotional celebration. Katie Powell, Alana's best friend from London, recalls, "It was her perfect wedding. She powered through, never complaining, with an attitude of 'what other option do I have?' She was my hero."
Raising Awareness and Funds After Loss
Alana passed away in October 2025, surrounded by loved ones, just eighteen months after her initial symptoms appeared. Katie is now sharing this heartbreaking narrative to mark AML Awareness Day, emphasising the urgent necessity for earlier diagnosis and enhanced access to cutting-edge treatments and clinical trials.
Blood Cancer UK reveals that merely three in ten individuals survive the hardest-to-treat blood cancers, including AML, with over 2,900 people diagnosed annually in the UK. Jane Nunnick, Senior Clinical Trials Nurse at the charity, stated, "Alana's story shows progress has been far too slow for some. Clinical trials are vital to provide access to latest treatments, and we urgently need more investment."
A Legacy of Encouragement and Action
Katie has since raised thousands for Blood Cancer UK through an 85-mile walk from London to Brighton and a half marathon, driven by Alana's enduring spirit. "If her story helps one person spot symptoms earlier, push for answers, or feel less alone, that's what she would have wanted," Katie affirmed.
This poignant case underscores a critical public health message: trust your instincts if symptoms persist unusually. Blood cancer remains the UK's third largest cancer killer, yet survival rates for aggressive types like AML lag significantly, highlighting a dire need for accelerated research and improved diagnostic protocols.
